Last reviewed · How we verify
Diclofenac 50mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Diclofenac 50mg (Diclofenac 50mg) — University of Maryland, Baltimore.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Diclofenac 50mg TARGET | Diclofenac 50mg | University of Maryland, Baltimore | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Diclofenac 50mg CI watch — RSS
- Diclofenac 50mg CI watch — Atom
- Diclofenac 50mg CI watch — JSON
- Diclofenac 50mg alone — RSS
Cite this brief
Drug Landscape (2026). Diclofenac 50mg — Competitive Intelligence Brief. https://druglandscape.com/ci/diclofenac-50mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab